Sukumar Nagendran - 02 Feb 2022 Form 4 Insider Report for Taysha Gene Therapies, Inc. (TSHA)

Role
Director
Signature
/s/ Kamran Alam, Attorney-in-Fact
Issuer symbol
TSHA
Transactions as of
02 Feb 2022
Net transactions value
+$80,100
Form type
4
Filing time
03 Feb 2022, 08:21:09 UTC
Previous filing
21 Jun 2021
Next filing
09 Jun 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TSHA Common Stock Purchase $80,100 +10,000 +52% $8.01* 29,226 02 Feb 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.